Boston Scientific’s stock climbs on Q3 sales and earnings beat

Shares of Boston Scientific Corp. rose 1.1% in premarket trades Wednesday after the medical products company reported better-than-expected profit and sales in its third-quarter results, and gave ... Read More

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices - Boston Scientific (NYSE:BSX) - Benzinga

Boston Scientific exceeded Q3 expectations with $4.21 billion revenue and $0.63 EPS. Cardiovascular sales rose 25%, and 2024 growth guidance was updated. Read More

Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High - MSN

Analysts projected $2.41 earnings per share and $16.3 billion in sales. In premarket trades on today's stock market, Boston Scientific stock rose 1.1%, signaling a possible record high at the open. Read More

Boston Scientific Q3 Earnings Preview - Forbes

Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates. Read More

Boston Scientific Corp Q3 adjusted earnings Beat Estimates

(RTTNews) - Below are the earnings highlights for Boston Scientific Corp (BSX): -Earnings: -$169 million in Q3 vs. $126 million in the same period last year. -EPS: -$0.12 in Q3 vs. $0.09 in the ... Read More

Boston Scientific’s stock jumps 3% after earnings beat and upbeat guidance - MarketWatch

Boston Scientific’s stock jumps 3% after earnings beat and upbeat guidance Medical tech company’s sales rose 14.9% in its latest quarter Last Updated: Jan. 31, 2024 at 7:14 a.m. ET First ... Read More

Boston Scientific’s stock climbs on Q3 sales and earnings beat - MSN

The company expects net sales growth for the full year 2024 to be approximately 16.5% on a reported basis and 15% on an organic basis. Boston Scientific expects full-year earnings between $1.28 ... Read More

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices - Yahoo Finance

On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter revenues of $4.21 billion, beating the consensus estimate of $4.04 billion. Sales increased 19.4% on a reported basis ... Read More

Boston Scientific's stock climbs on Q3 sales and earnings beat

Related: Boston Scientific's stock jumps 3% after earnings beat and upbeat guidance The company expects net sales growth for the full year 2024 to be approximately 16.5% on a reported basis and 15 ... Read More